New Delhi: The government has approved the Corbevax booster dose of Biologic E Company. This booster dose will be given to adults above 18 years of age. Official sources said that the Corbevax vaccine, developed by Biological E by the Union Health Ministry, has been approved as a precautionary dose for people above 18 years of age who have taken the first two doses of Covishield or Covaxin. Sources said that this permission is based on the recommendation made last week by the Kovid-19 Working Group of the National Technical Advisory Group on Immunization (NTAGI).
Corbevax is the first vaccine in the country to be given as a precautionary dose apart from the first and second doses. That is, a person who has taken any of the vaccines from Covaccine or Covishield can get a booster dose of Corbevax. Significantly, India’s first indigenous RBD protein subunit vaccine, Corbevax, is currently being used to immunize children aged 12 to 14 years as part of the Kovid-19 vaccination program. Significantly, the Drug Controller General of India (GCGI) on June 4 allowed Corbevax to be administered to people aged 18 and above as a third dose.
The Covid-19 Working Group reviewed the data for the third phase in its meeting on July 20. In this, Covid-19 negative people aged 18 to 80 years who had taken the first two doses of Covishield or Covaxin, the effect on their immunity after Corbevax vaccine was given as a third dose. Sources said, after examining the data, the CWG found that those taking Covavax as the first and second dose or Covishield can be given Corbevax as a third dose, which can produce significant levels of antibodies (to fight the virus), the sources said. Produces and according to neutral statistics is probably also defensive.
